About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in San Diego | 128 Studies

Clinical Trials Prostate CancerSan Diego

Prostate Cancer Clinical Trials in San Diego

Find 128 clinical trials for prostate cancer near San Diego, California. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in San Diego

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 41-60 of 128 trials

RecruitingTargeted Treatment for Metastatic Prostate Cancer, The PREDICT TrialThis phase II trial evaluates whether genetic testing in prostate cancer is helpful in deciding which study treatment patients are assigned.NCT06632977·Birmingham, Alabama and 107 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedChemotherapy After Prostatectomy (CAP) For High Risk Prostate CarcinomaVA Cooperative Study #553 is designed to prospectively evaluate the efficacy of early adjuvant chemotherapy using docetaxel and prednisone added to the standard of care for…NCT00132301·Birmingham, Alabama and 33 others

CompletedRadiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells and shrink tumors. Androgens can cause the growth of prostate cancer cells.NCT00936390·Birmingham, Alabama and 517 others

WithdrawnStudy of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective.The purpose of this clinical research study is to assess the safety and efficacy of an investigational therapy called DCVax(TM)-Prostate.NCT00043212·Springdale, Arkansas and 15 others

CompletedPROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone TherapyPROSTVAC-VF is an investigational cancer vaccine.NCT00078585·Homewood, Alabama and 46 others

Active not recruitingStudy of Oral MRT-2359 in Selected Cancer PatientsThis Phase 1/2, open-label, multicenter study is conducted in patients with previously treated selected solid tumors, including non-small cell lung cancer (NSCLC), small cell lung…NCT05546268·Scottsdale, Arizona and 16 others

Active not recruitingTwo Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT TrialThis phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer…NCT04513717·Fairbanks, Alaska and 601 others

RecruitingPhase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate CancerThis is an open label, phase I, multi-center study aiming to assess the safety and tolerability in patients with metastatic castration resistant prostate cancer (mCRPC).NCT06801236·La Jolla, California and 12 others

CompletedS1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate CancerThe purpose of this study is to compare overall survival in newly diagnosed metastatic prostate cancer patients randomly assigned to androgen deprivation therapy (ADT) + TAK-700…NCT01809691·Birmingham, Alabama and 559 others

CompletedStudy of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate CancerThis study is being done to evaluate the safety and efficacy of atrasentan in men with non-metastatic hormone-refractory prostate cancer.NCT00036556·Homewood, Alabama and 233 others

CompletedEfficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate CancerThe objective of this study is to assess the response of patupilone plus prednisone compared to docetaxel plus prednisone on prostate specific antigen (PSA) in patients with…NCT00411528·La Jolla, California and 31 others

UnknownEnzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate CancerThis randomized phase III trial studies enzalutamide to see how well it works compared to enzalutamide, abiraterone, and prednisone in treating patients with castration-resistant…NCT01949337·Birmingham, Alabama and 538 others

RecruitingA Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)The purpose of this study is to evaluate the overall survival (length of time from the start of study to date of death from any cause) for pasritamig (JNJ-78278343) in Part 1 in…NCT07164443·La Jolla, California and 175 others

RecruitingInternational Registry for Men With Advanced Prostate Cancer (IRONMAN)Our intent is to establish the International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN) as a prospective, international cohort of minimum 5,000…NCT03151629·Birmingham, Alabama and 120 others

CompletedTreatment of Prostate Cancer With Adjuvant Bevacizumab Plus ErlotinibThe purpose of this study is to evaluate the safety and effectiveness of bevacizumab plus erlotinib following radical prostatectomy.NCT00203424·Alhambra, California and 15 others

TerminatedProspective Prolaris Value and EfficacyThis is a prospective study to measure the impact on first-line therapy of genomic testing of biopsy tissue from recently diagnosed treatment-naïve patients with early stage…NCT03152448·San Diego, California and 11 others

CompletedSafety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based ChemotherapyThis is a phase 3 study to compare the clinical benefit of MDV3100 versus placebo in patients with castration-resistant prostate cancer who have been previously treated with…NCT00974311·Birmingham, Alabama and 248 others

UnknownNon-contrast MR Imaging for Whole Body Cancer Detection and CharacterizationThis study aims to learn how to improve MRIs (Magnetic Resonance Imaging) that do not require the patient to be injected with a contrast dye.NCT03440554·La Jolla, California

RecruitingA Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)This study will assess the safety and tolerability of valemetostat in combination with darolutamide in participants with Metastatic Castration Resistant Prostate Cancer (mCRPC).NCT07244341·La Jolla, California and 28 others

UnknownRandomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509)This research study is comparing two different combinations of androgen deprivation therapy (ADT) used together with radiation as a treatment for rising PSA after radical…NCT03141671·San Diego, California and 7 others

PreviousPage 3 of 7Next

Other Conditions in San Diego

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma